title: Comment on: efficacy of omega-3 fatty acid supplementation on serum levels of tumour necrosis factor-alpha, C-reactive protein and interleukin-2 in type 2 diabetes mellitus patients.
authors: Martin
authors: M
authors: Hofmeister
mesh_terms: D002097:C-Reactive Protein / Q000378:metabolism*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D019587:Dietary Supplements; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007249:Inflammation / Q000517:prevention & control*; D007376:Interleukin-2 / Q000097:blood*; D008297:Male; D014409:Tumor Necrosis Factor-alpha / Q000097:blood*
chemical_list: D015525:Fatty Acids, Omega-3; D007376:Interleukin-2; D014409:Tumor Necrosis Factor-alpha; D002097:C-Reactive Protein